CoChat
Sign Up
Cited by 47

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Basophil Activation as Marker of Clinically Relevant Allergy and Therapy Outcome

Eberlein, Bernadette·2020·Frontiers in Immunology
DOI 10.3389/fimmu.2020.01815PMC PMC7472882
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2020.01815

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 78

  1. Hoffmann, 2015, The clinical utility of basophil activation testing in diagnosis and monitoring of allergy disease, Allergy., 70, 1393, 10.1111/all.12698 · DOI
  2. Santos, 2015, Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut, J Allergy Clin Immunol., 135, 179, 10.1016/j.jaci.2014.09.001 · DOI
  3. Hemmings, 2018, The basophil activation test: old and new applications in allergy, Curr Allergy Asthma Rep., 18, 77, 10.1007/s11882-018-0831-5 · DOI
  4. Mehlich, 2019, The basophil activation test differentiates between patients with alpha-gal syndrome and asymptomatic alpha-gal sensitization, J Allergy Clin Immunol., 143, 182, 10.1016/j.jaci.2018.06.049 · DOI
  5. Santos, 2014, Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children, J Allergy Clin Immunol., 134, 645, 10.1016/j.jaci.2014.04.039 · DOI
  6. Glaumann, 2012, Basophil allergen threshold sensitivity, CD-sens, IgE-sensitization and DBPCFC in peanut-sensitized children, Allergy., 67, 242, 10.1111/j.1398-9995.2011.02754.x · DOI
  7. Chinthrajah, 2018, Development of a tool predicting severity of allergic reaction during peanut challenge, Ann Allergy Asthma Immunol., 121, 69, 10.1016/j.anai.2018.04.020 · DOI
  8. Chapuis, 2018, Ara h 2 basophil activation test does not predict clinical reactivity to peanut, J Allergy Clin Immunol Pract., 6, 1772, 10.1016/j.jaip.2018.01.021 · DOI
  9. Rubio, 2011, Benefit of the basophil activation test in deciding when to reintroduce cow's milk in allergic children, Allergy., 66, 92, 10.1111/j.1398-9995.2010.02432.x · DOI
  10. Ford, 2013, Basophil reactivity, wheal size, and immunoglobulin levels distinguish degrees of cow's milk tolerance, J Allergy Clin Immunol., 131, 180, 10.1016/j.jaci.2012.06.003 · DOI
  11. Ruinemans-Koerts, 2019, The basophil activation test reduces the need for a food challenge test in children suspected of IgE-mediated cow's milk allergy, Clin Exp Allergy., 49, 350, 10.1111/cea.13307 · DOI
  12. Berin, 2018, Egg-specific IgE and basophil activation but not egg-specific T-cell counts correlate with phenotypes of clinical egg allergy, J Allergy Clin Immunol., 142, 149, 10.1016/j.jaci.2018.01.044 · DOI
  13. Lötzsch, 2016, Exploratory analysis of CD63 and CD203c expression in basophils from hazelnut sensitized and allergic individuals, Clin Transl Allergy., 13, 6, 10.1186/s13601-016-0134-7 · DOI
  14. Deng, 2019, Clinical utility of basophil activation test in diagnosis and predicting severity of mugwort pollen-related peach allergy, World Allergy Organ J., 12, 100043, 10.1016/j.waojou.2019.100043 · DOI
  15. Chinuki, 2012, CD203c expression–based basophil activation test for diagnosis of wheat-dependent exercise-induced anaphylaxis, J. Allergy Clin. Immunol., 1404, 10.1016/j.jaci.2012.02.049 · DOI
  16. Nilsson, 2013, Combining analyses of basophil allergen threshold sensitivity, CD-sens, and IgE antibodies to hydrolyzed wheat, ω-5 gliadin and timothy grass enhances the prediction of wheat challenge outcome, Int Arch Allergy Immunol., 162, 50, 10.1159/000350923 · DOI
  17. Appel, 2018, Evaluation of the basophil activation test and skin prick testing for the diagnosis of sesame food allergy, Clin Exp Allergy., 48, 1025, 10.1111/cea.13174 · DOI
  18. Eberlein-König, 2006, In vitro basophil activation using CD63 expression in patients with bee and wasp venom allergy, J Investig Allergol Clin Immunol., 16, 5
  19. Korosec, 2009, Basophil responsiveness in patients with insect sting allergies and negative venom-specific immunoglobulin E and skin prick test results, Clin Exp Allergy., 39, 1730, 10.1111/j.1365-2222.2009.03347.x · DOI
  20. Ebo, 2013, Component-resolved diagnosis of wasp (yellow jacket) venom allergy, Clin Exp Allergy., 43, 255, 10.1111/cea.12057 · DOI
  21. Schiener, 2017, Application of recombinant antigen 5 allergens from seven allergy-relevant Hymenoptera species in diagnostics, Allergy., 72, 98, 10.1111/all.13000 · DOI
  22. Eberlein-König, 2004, Use of CD63 expression as marker of in vitro basophil activation in identifying the culprit in insect venom allergy, J Investig Allergol Clin Immunol., 14, 10
  23. Sturm, 2011, Inconsistent results of diagnostic tools hamper the differentiation between bee and vespid venom allergy, PLoS ONE., 6, e20842, 10.1371/journal.pone.0020842 · DOI
  24. Eberlein, 2012, Double positivity to bee and wasp venom: improved diagnostic procedure by recombinant allergen-based IgE testing and basophil activation test including data about cross-reactive carbohydrate determinants, J Allergy Clin Immunol., 130, 155, 10.1016/j.jaci.2012.02.008 · DOI
  25. Bokanovic, 2020, Possible utility of basophil activation test in dual honeybee and vespid sensitization, J Allergy Clin Immunol Pract., 8, 392, 10.1016/j.jaip.2019.06.008 · DOI
  26. Zidarn, 2019, Clinical and immunological differences between asymptomatic HDM-sensitized and HDM-allergic rhinitis patients, Clin Exp Allergy., 49, 808, 10.1111/cea.13361 · DOI
  27. Duarte Ferreira, 2019, Contribution of in vivo and in vitro testing for the diagnosis of local allergic rhinitis, J Investig Allergol Clin Immunol., 29, 46, 10.18176/jiaci.0321 · DOI
  28. Campo, 2015, Immunologic responses to the major allergen of olea europaea in local and systemic allergic rhinitis subjects, Clin Exp Allergy., 45, 1702, 10.1111/cea.12600 · DOI · Paper page
  29. Mayorga, 2017, The value of in vitro tests to diminish drug challenges, Int J Mol Sci., 7, 18, 10.3390/ijms18061222 · DOI
  30. Decuyper, 2017, In vitro diagnosis of immediate drug hypersensitivity anno 2017: Potentials and limitations, Drugs R D., 17, 265, 10.1007/s40268-017-0176-x · DOI
  31. Takazawa, 2019, In vitro diagnostic tests for perioperative hypersensitivity, a narrative review: potential, limitations, and perspectives, Br J Anaesth., 123, e117, 10.1016/j.bja.2019.01.002 · DOI
  32. Garvey, 2019, An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions, Allergy., 74, 1872, 10.1111/all.13820 · DOI
  33. Li, 2019, Integrating basophil activation tests into evaluation of perioperative anaphylaxis to neuromuscular blocking agents, Br J Anaesth., 123, e135, 10.1016/j.bja.2019.02.024 · DOI
  34. Kim, 2011, Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization, J Allergy Clin Immunol., 127, 640, 10.1016/j.jaci.2010.12.1083 · DOI
  35. Burks, 2015, Sublingual immunotherapy for peanut allergy: long-term follow-up of a randomized multicenter trial, J Allergy Clin Immunol., 135, 1240, 10.1016/j.jaci.2014.12.1917 · DOI
  36. Syed, 2014, Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3), J Allergy Clin Immunol., 133, 500, 10.1016/j.jaci.2013.12.1037 · DOI
  37. Kim, 2019, Long-term sublingual immunotherapy for peanut allergy in children: clinical and immunologic evidence of desensitization, J Allergy Clin Immunol., 144, 1320, 10.1016/j.jaci.2019.07.030 · DOI
  38. Nucera, 2015, Utility of basophil activation test for monitoring the acquisition of clinical tolerance after oral desensitization to cow's milk: pilot study, United European Gastroenterol J., 3, 272, 10.1177/2050640615570694 · DOI
  39. Elizur, 2016, Clinical and laboratory 2-year outcome of oral immunotherapy in patients with cow's milk allergy, Allergy, 71, 275, 10.1111/all.12794 · DOI
  40. Vila, 2013, Decrease in antigen-specific CD63 basophil expression is associated with the development of tolerance to egg by SOTI in children, Pediatr Allergy Immunol., 24, 463, 10.1111/pai.12070 · DOI
  41. Gamboa, 2016, Is the quantification of antigen-specific basophil activation a useful tool for monitoring oral tolerance induction in children with egg allergy?, J Investig Allergol Clin Immunol., 26, 25, 10.18176/jiaci.0004 · DOI
  42. Garrido-Fernández, 2014, Are basophil activation and sulphidoleukotriene determination useful tests for monitoring patients with peach allergy receiving sublingual immunotherapy with a Pru p 3-enriched peach extract?, J Investig Allergol Clin Immunol., 24, 106
  43. Gomez, 2017, The clinical and immunological effects of Pru p 3 sublingual immunotherapy on peach and peanut allergy in patients with systemic reactions, Clin Exp Allergy., 47, 339, 10.1111/cea.12901 · DOI
  44. Erdmann, 2004, The basophil activation test in wasp venom allergy: sensitivity, specificity and monitoring specific immunotherapy, Allergy., 59, 1102, 10.1111/j.1398-9995.2004.00624.x · DOI
  45. Ebo, 2007, Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy, Cytometry B Clin Cytom., 72, 196, 10.1002/cyto.b.20142 · DOI
  46. Eržen, 2012, Basophil response and the induction of a tolerance in venom immunotherapy: a long-term sting challenge study, Allergy., 67, 822, 10.1111/j.1398-9995.2012.02817.x · DOI
  47. Žitnik, 2012, Monitoring honeybee venom immunotherapy in children with the basophil activation test, Pediatr Allergy Immunol, 23, 166, 10.1111/j.1399-3038.2011.01233.x · DOI
  48. Bidad, 2014, Basophil activation test in the diagnosis and monitoring of mastocytosis patients with wasp venom allergy on immunotherapy, Cytometry B Clin Cytom., 86, 183, 10.1002/cytob.21181 · DOI
  49. Rodriguez Trabado, 2016, Short-, intermediate-, and long-term changes in basophil reactivity induced by venom immunotherapy, Allergy Asthma Immunol Res., 8, 412, 10.4168/aair.2016.8.5.412 · DOI
  50. Kucera, 2010, Basophil activation can predict clinical sensitivity in patients after venom immunotherapy, J Investig Allergol Clin Immunol., 20, 110
  51. Arzt, 2018, Immunological differences between insect venom-allergic patients with and without immunotherapy and asymptomatically sensitized subjects, Allergy, 73, 1223, 10.1111/all.13368 · DOI
  52. Peternelj, 2008, Basophil sensitivity in patients not responding to venom immunotherapy, Int Arch Allergy Immunol., 146, 248, 10.1159/000116361 · DOI
  53. Nagao, 2008, Allergen-induced basophil CD203c expression as a biomarker for rush immunotherapy in patients with Japanese cedar pollinosis, Int Arch Allergy Immunol, 146, 47, 10.1159/000126061 · DOI
  54. Nopp, 2009, CD-sens: a biological measure of immunological changes stimulated by ASIT, Allergy., 64, 811, 10.1111/j.1398-9995.2008.01900.x · DOI · Paper page
  55. Özdemir, 2014, Short-term preseasonal immunotherapy: is early clinical efficacy related to the basophil response?, Int Arch Allergy Immunol., 164, 237, 10.1159/000365628 · DOI
  56. Gokmen, 2012, Desensitization effect of preseasonal seven-injection allergoid immunotherapy with olive pollen on basophil activation: the efficacy of olive pollen-specific preseasonal allergoid immunotherapy on basophils, Int Arch Allergy Immunol., 159, 75, 10.1159/000335251 · DOI
  57. Aasbjerg, 2014, Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy, Clin Exp Allergy., 44, 417, 10.1111/cea.12241 · DOI
  58. Schmid, 2020, Basophil sensitivity reflects long-term clinical outcome of subcutaneous immunotherapy in grass pollen-allergic patients, Allergy, 10.1111/all.14264. · DOI
  59. Zidarn, 2015, Sustained effect of grass pollen subcutaneous immunotherapy on suppression of allergen-specific basophil response; a real-life, nonrandomized controlled study, Allergy., 70, 547, 10.1111/all.12581 · DOI · Paper page
  60. Van Overtvelt, 2011, Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy, Allergy., 66, 1530, 10.1111/j.1398-9995.2011.02696.x · DOI
  61. Czarnobilska, 2018, The usefulness of the basophil activation test in monitoring specific immunotherapy with house dust mite allergens, Postepy Dermatol Alergol., 35, 93, 10.5114/ada.2018.73169 · DOI
  62. Sánchez, 2014, Effect of immunotherapy on basophil activation induced by allergens in patients with atopic dermatitis, Rev Alerg Mex., 61, 168, 10.29262/ram.v61i3.42 · DOI
  63. Kim, 2018, Changes in basophil activation during immunotherapy with house dust mite and mugwort in patients with allergic rhinitis, Asia Pac Allergy., 24, 8, 10.5415/apallergy.2018.8.e6 · DOI
  64. Swamy, 2012, Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy, J Allergy Clin Immunol., 130, 215, 10.1016/j.jaci.2012.04.021 · DOI · Paper page
  65. Lasa Luaces, 2012, Component-resolved immunologic modifications, efficacy, and tolerance of latex sublingual immunotherapy in children, Ann. Allergy Asthma Immunol., 108, 367, 10.1016/j.anai.2012.03.005 · DOI
  66. Luyasu, 2011, Anaphylactic shock due to recombinant human insulin: follow-up of a desensitization protocol by basophil activation test, Rev Med Internet., 32, 39, 10.1016/j.revmed.2010.10.350 · DOI
  67. González-de-Olano, 2016, Positive basophil activation test following anaphylaxis to pertuzumab and successful treatment with rapid desensitization, J Allergy Clin Immunol Pract., 4, 338, 10.1016/j.jaip.2015.10.007 · DOI
  68. Thévenot, 2019, Rapid desensitization to adalimumab is associated with decreased basophil sensitivity, J Investig Allergol Clin Immunol., 29, 141, 10.18176/jiaci.0350 · DOI
  69. de la Varga Martínez, 2017, Use of the basophil activation test in monitoring clinical tolerance after desensitization to brentuximab vedotin, Ann Allergy Asthma Immunol., 118, 745, 10.1016/j.anai.2017.04.015 · DOI
  70. De la Varga Martínez, 2017, Rapid subcutaneous desensitization for treatment of hypersensitivity reactions to etanercept in two patients with positive basophil activation test, Allergol Int., 66, 357, 10.1016/j.alit.2016.09.002 · DOI
  71. Giavina-Bianchi, 2017, Basophil activation test is a relevant biomarker of the outcome of rapid desensitization in platinum compounds-allergy, J Allergy Clin Immunol Pract., 5, 728, 10.1016/j.jaip.2016.11.006 · DOI
  72. Jörg, 2018, Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients, Clin Exp Allergy., 48, 196, 10.1111/cea.13066 · DOI
  73. Brandström, 2017, Individually dosed omalizumab: an effective treatment for severe peanut allergy, Clin Exp Allergy., 47, 540, 10.1111/cea.12862 · DOI
  74. Brandström, 2014, Individually dosed omalizumab facilitates peanut oral immunotherapy in peanut allergic adolescents, Clin Exp Allergy., 49, 1328, 10.1111/cea.13469 · DOI
  75. Nilsson, 2014, Successful management of severe cow's milk allergy with omalizumab treatment and CD-sens monitoring, Asia Pac Allergy., 4, 257, 10.5415/apallergy.2014.4.4.257 · DOI
  76. Nopp, 2006, Basophil allergen threshold sensitivity: a useful approach to anti-IgE treatment efficacy evaluation, Allergy., 61, 298, 10.1111/j.1398-9995.2006.00987.x · DOI · Paper page
  77. Johansson, 2009, The size of the disease relevant IgE antibody fraction in relation to ‘total-IgE' predicts the efficacy of anti-IgE (Xolair) treatment, Allergy., 64, 1472, 10.1111/j.1398-9995.2009.02051.x · DOI
  78. Nopp, 2007, CD-sens and clinical changes during withdrawal of xolair after 6 years of treatment, Allergy., 62, 1175, 10.1111/j.1398-9995.2007.01476.x · DOI

Cited by

Sorted by citations

See all 47

Metadata

Authors
Eberlein, B.
Venue
Frontiers in Immunology
Publisher
Frontiers Media SA
Published
2020-08-21
Volume
11
ISSN
1664-3224
DOI
10.3389/fimmu.2020.01815
PMC
PMC7472882
Cited by
47
References
1
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Basophil Activation as Marker of Clinically Relevant Allergy and Therapy Outcome. https://app.cochat.ai/papers/10.3389/fimmu.2020.01815
The paper
Eberlein, B. (2020). Basophil Activation as Marker of Clinically Relevant Allergy and Therapy Outcome. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2020.01815